PTB patients often experience inflammation due to recurrent tissue damage and repair, with some underlying infections causing inflammation that results in the production of inflammatory factors, such as interleukin (IL) and tumor necrosis factor (TNF), during their long-term treatment. This evidence concerns the gene TNF and infection.